Successful Switch of Patients with Rheumatoid Arthritis Developing Anti-tumor Necrosis Factor (anti-TNF)-induced Lupus to Another Anti-TNF Agent

REFERENCES

1. 1.↵
   1. Soforo E,
   2. Baumgartner M,
   3. Francis L,
   4. Allam F,
   5. Phillips PE,
   6. Perl A

   . Induction of systemic lupus erythematosus with tumor necrosis factor blockers [letter]. J Rheumatol 2010;37:204–5.

   OpenUrlFREE Full Text
2. 2.↵
   1. Jacob N,
   2. Jacob CO

   . On anti-tumor necrosis factor-induced systemic lupus erythematosus. J Rheumatol 2010;37:3–5.

   OpenUrlFREE Full Text
3. 3.↵
   1. Benucci M,
   2. Saviola G,
   3. Baiardi P,
   4. Cammelli E,
   5. Manfredi M

   . Anti-nucleosome antibodies as prediction factor of development of autoantibodies during therapy with three different TNF-α blocking agents in rheumatoid arthritis. Clin Rheumatol 2008;27:91–5.

   OpenUrlCrossRefPubMed
4. 4.↵
   1. DeRycke L,
   2. Baeten D,
   3. Kruithof E,
   4. Van de Bosch F,
   5. Veys EM,
   6. Dekeyser F

   . Infliximab, but not etanercept, induces IgM anti-double-stranded DNA antibodies as main antinuclear reactivity: biologic and clinical implications in autoimmune arthritis. Arthritis Rheum 2005;52:2192–201.

   OpenUrlCrossRefPubMed
5. 5.↵
   1. Costa MF,
   2. Said NR,
   3. Zimmerman B

   . Drug-induced lupus due to anti-tumour necrosis factor alpha agents. Semin Arthritis Rheum 2008;37:381–7.

   OpenUrlCrossRefPubMed
6. 6.↵
   1. Luong J,
   2. Tan B,
   3. Buchanan R,
   4. Schachna L

   . Tumour necrosis factor inhibitor-related lupus: safety of switching agents. Clin Rheumatol 2010;29:551–3.

   OpenUrlCrossRefPubMed
7. 7.↵
   1. Wetter DA,
   2. Davis MD

   . Lupus-like syndrome attributable to anti-tumor necrosis factor alpha therapy in 14 patients during an 8-year period at Mayo Clinic. Mayo Clin Proc 2009;84:979–84.

   OpenUrlCrossRefPubMed
8. 8.↵
   1. Kocharla L,
   2. Mongey AB

   . Is the development of drug-induced lupus a contraindication for switching from one TNF alpha inhibitor to another? Lupus 2009;18:169–71.

   OpenUrlAbstract/FREE Full Text
9. 9.↵
   1. De Bandt M,
   2. Sibilia J,
   3. Le Loet X,
   4. Prouzeau S,
   5. Fautrel B,
   6. Marcelli C,
   7. et al.

   Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: a French national survey. Arthritis Res Ther 2005;7:545–51.

   OpenUrlCrossRef
10. 10.↵
    1. Cavazzana I,
    2. Bobbio-Pallavicini F,
    3. Franceschini F,
    4. Bazzani C,
    5. Ceribelli A,
    6. Bravi E,
    7. et al.

    Anti-TNF-alpha treatment in rheumatoid arthritis with anti-Ro/SSA antibodies. Analysis of 17 cases among a cohort of 322 treated patients. Clin Exp Rheumatol 2007;25:676–83.

    OpenUrlPubMed